Last reviewed · How we verify

NCT05581394

Accuracy of BabySat V3 With Profound Hypoxia and Motion

Completed Last updated 14 October 2022
What this trial tests

trial testing BabySat V3 in Hypoxia in 12 participants. Completed in 15 July 2022.

Timeline
14 July 2022
Primary endpoint
15 July 2022
15 July 2022

Quick facts

Lead sponsorOwlet Baby Care, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date14 July 2022
Primary completion15 July 2022
Estimated completion15 July 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Owlet Baby Care, Inc.

Who can join

Adults 18 to 49, any sex, with Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained and during different motion scenarios. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

Other Owlet Baby Care, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05581394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing